$279.83
+ $2.14 (0.76%)
End-of-day quote: 05/03/2024
NYSE:BIO

Bio-Rad Laboratories Inc Annual Report

Year Year 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
Rev. Revenue
$2.67B $2.80B $2.92B $2.55B $2.31B $2.29B $2.16B $2.07B $2.02B $2.18B $2.13B $2.07B $2.07B $1.93B $1.78B $1.76B $1.46B $1.27B $1.18B $1.09B
GM % Gross Margin %
53.56% 55.97% 56.91% 56.41% 54.57% 53.66% 55.08% 55.15% 55.54% 54.45% 55.26% 55.83% 56.85% 56.64% 56.04% 54.55% 54.16% 55.93% 54.74% 55.97%
OM Operating Margin
13.69% 17.38% 19.33% 16.06% 10.94% 8.52% 7.05% 7.20% 8.26% 7.13% 7.67% 11.99% 14.72% 14.74% 13.16% 12.00% 9.78% 11.79% 9.76% 11.33%
EPS Earnings Per Share
$0.00 $11.78 $14.42 $15.66 $10.52 $7.06 $5.84 $3.82 $2.64 $3.85 $4.17 $3.90 $5.80 $6.26 $6.21 $5.33 $4.30 $3.79 $3.53 $3.44 $2.87
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0.00% 0.00% 0.00% 0.00% 0.00% 0 0 0 0 0 0 0.00% 0.00% 0 0 0 0 0.00% 0.00% 0
Sha. Shares
28.52m 29.6m 29.93m 29.84m 29.93m 29.8m 29.79m 29.58m 29.36m 29.07m 28.78m 28.48m 28.18m 27.85m 27.53m 27.32m 26.88m 26.5m 26.23m 25.83m
OCF Operating Cash Flow
$374.90M $194.40M $669.50M $575.33M $457.90M $285.49M $104.14M $216.07M $186.21M $273.31M $169.14M $266.48M $262.74M $225.91M $325.07M $191.37M $191.58M $118.23M $108.28M $123.10M
FCF Free Cash Flow
$424.08M $93.70M $535.72M $476.41M $359.37M $155.67M $-7.45M $75.00M $74.21M $152.31M $62.48M $126.48M $156.93M $138.65M $258.27M $106.56M $-196.09M $65.24M $72.22M $62.61M
FCFS Free Cash Flow Per Share
$7.47 $2.69 $17.96 $16.12 $12.34 $5.22 $-0.37 $2.53 $2.50 $4.74 $2.16 $4.31 $5.69 $4.82 $9.03 $3.78 $4.83 $2.47 $2.58 $2.05